Revelation Biosciences, Inc. (NASDAQ:REVB) Short Interest Update

by · The Markets Daily

Revelation Biosciences, Inc. (NASDAQ:REVB – Get Free Report) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 240,400 shares, an increase of 450.1% from the December 15th total of 43,700 shares. Currently, 2.9% of the shares of the company are short sold. Based on an average daily volume of 2,980,000 shares, the days-to-cover ratio is presently 0.1 days.

Revelation Biosciences Price Performance

Shares of REVB traded down $0.03 during midday trading on Tuesday, reaching $0.47. 416,290 shares of the stock were exchanged, compared to its average volume of 14,573,462. The company has a market capitalization of $2.02 million, a price-to-earnings ratio of -0.03 and a beta of 0.24. Revelation Biosciences has a twelve month low of $0.28 and a twelve month high of $25.26. The business’s 50-day moving average price is $0.60 and its 200 day moving average price is $0.96.

Revelation Biosciences Company Profile

(Get Free Report)

Revelation Biosciences, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease.

Featured Articles